Feifei Yang

2.5k total citations
76 papers, 1.3k citations indexed

About

Feifei Yang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Feifei Yang has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Feifei Yang's work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). Feifei Yang is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). Feifei Yang collaborates with scholars based in China, United States and Russia. Feifei Yang's co-authors include Yijin Liu, P. Pianetta, Liwei Mi, Weihua Chen, Ziyu Wu, Shizhong Cui, Kailu Guo, Joy C. Andrews, Surendra K. Martha and Gene E. Ice and has published in prestigious journals such as Nano Letters, PLoS ONE and Neurology.

In The Last Decade

Feifei Yang

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Yang China 21 447 221 199 182 180 76 1.3k
Jiali Cao China 20 321 0.7× 343 1.6× 197 1.0× 59 0.3× 149 0.8× 78 1.2k
Jing Xue China 23 519 1.2× 241 1.1× 269 1.4× 338 1.9× 124 0.7× 91 1.6k
Zhongping Liu China 20 278 0.6× 81 0.4× 291 1.5× 163 0.9× 99 0.6× 71 1.2k
Yunfei Li China 23 171 0.4× 59 0.3× 327 1.6× 193 1.1× 172 1.0× 77 1.5k
Lulu Zheng China 25 336 0.8× 176 0.8× 271 1.4× 81 0.4× 46 0.3× 81 1.4k
Bolin Zhao China 22 668 1.5× 200 0.9× 373 1.9× 390 2.1× 87 0.5× 87 1.4k
Hiroshi Irie Japan 26 376 0.8× 169 0.8× 423 2.1× 87 0.5× 294 1.6× 124 2.1k
Yunli Zhang China 17 314 0.7× 65 0.3× 341 1.7× 40 0.2× 82 0.5× 112 1.2k
Yufeng Cai China 19 429 1.0× 108 0.5× 202 1.0× 240 1.3× 58 0.3× 37 1.8k
Yanning Liu China 14 330 0.7× 121 0.5× 129 0.6× 25 0.1× 103 0.6× 46 845

Countries citing papers authored by Feifei Yang

Since Specialization
Citations

This map shows the geographic impact of Feifei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Yang more than expected).

Fields of papers citing papers by Feifei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Yang. The network helps show where Feifei Yang may publish in the future.

Co-authorship network of co-authors of Feifei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Yang. A scholar is included among the top collaborators of Feifei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Yang. Feifei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Rui, Feifei Yang, Xinyuan Xu, et al.. (2025). The bacterial spectrum of spinal infections based on blood culture, tissue culture, and molecular methods: a systematic review and meta-analysis. Scientific Reports. 15(1). 45566–45566.
3.
Li, Mengyao, et al.. (2024). Targeted discovery of clerodane diterpenoids from Tinospora sinensis as immunomodulatory agents. Fitoterapia. 178. 106174–106174. 5 indexed citations
4.
He, Zhangxu, Weiguang Yang, Feifei Yang, Jingyu Zhang, & Liying Ma. (2024). Innovative medicinal chemistry strategies for enhancing drug solubility. European Journal of Medicinal Chemistry. 279. 116842–116842. 4 indexed citations
5.
Geng, Hao, et al.. (2024). Study on the control of macro/semi-macro segregation in unevenly solidified slabs through optimizing soft reduction process. Ironmaking & Steelmaking Processes Products and Applications. 53(2). 315–327. 1 indexed citations
6.
Yang, Feifei, et al.. (2024). Otitis media with effusion in adults during the SARS-CoV-2 epidemic. Science Progress. 107(1). 342202155–342202155. 1 indexed citations
7.
Liu, Jingrui, et al.. (2023). COVID-19-related secretory otitis media in the omicron era: a case series. European Archives of Oto-Rhino-Laryngology. 280(10). 4697–4700. 5 indexed citations
8.
Zhang, Yao, Xueyun Zhang, Yifei Guo, et al.. (2023). Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology. 2023. 1–12. 1 indexed citations
9.
Zhang, Yao, Xueyun Zhang, Jiajia Han, et al.. (2023). Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure. Hepatology International. 17(4). 1000–1015. 7 indexed citations
10.
Zhang, Yao, Jiajia Han, Xueyun Zhang, et al.. (2022). Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon. Liver International. 43(2). 329–339. 9 indexed citations
11.
Li, Ning, Kangkang Yu, Minhui Dong, et al.. (2022). Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy. Emerging Microbes & Infections. 11(1). 1876–1889. 7 indexed citations
13.
Li, Ning, Feifei Yang, Juan Su, et al.. (2021). Structure characterization of an arabinogalactan from Cynanchum atratum and its immune stimulatory activity on RAW264.7 cells. International Journal of Biological Macromolecules. 194. 163–171. 23 indexed citations
14.
Terekhov, Roman P., et al.. (2020). Comparative study of wound-healing activity of taxifolin pseudopolymorphic modifications. Bulletin of Experimental Biology and Medicine. 170(10). 452–456. 2 indexed citations
15.
Yang, Feifei, Xueping Yu, Chenliang Zhou, et al.. (2019). Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathogens. 15(4). e1007690–e1007690. 59 indexed citations
16.
Dong, Minhui, Jingwen Wu, Xueping Yu, et al.. (2018). Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver International. 38(9). 1562–1570. 35 indexed citations
17.
Hsi, Ryan S., et al.. (2017). Anatomically-specific intratubular and interstitial biominerals in the human renal medullo-papillary complex. PLoS ONE. 12(11). e0187103–e0187103. 7 indexed citations
18.
Ruan, Qiaoling, et al.. (2017). A 60-Year-Old Man With Fever and Headache After a Near-Drowning Event. Clinical Infectious Diseases. 66(2). 314–315.
19.
Li, Xinyan, Fahong Li, Yao Zhang, et al.. (2015). Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity. Biochemical and Biophysical Research Communications. 464(4). 1185–1191. 3 indexed citations
20.
Ban, Dayan, et al.. (1996). Study of valence band offsets of Ge/ZnS(111) heterojunctions by synchrotron radiation photoemission. 中国科学A辑(英文版). 39(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026